|
Patient demographics and characteristics |
|
| Characteristic |
Patients (n = 3415) |
|
|
|
| Male, % |
35 |
| Mean age ± SD, years |
45.2 ± 16.7 |
| Recruitment of patients*, n (%) |
|
| PCP |
2600 (76) |
| Specialist |
785 (23) |
| Mean asthma duration, years |
16.0 |
| Current smokers, n (%) |
714 (21) |
| Daily maintenance therapy prescribed, n (%)† |
|
| ICS no LABA |
1018 (30) |
| ICS plus LABA |
2393 (70) |
| Budesonide/formoterol |
769 (23) |
| Salmeterol/fluticasone |
1305 (38) |
| Self-assessed overall health when feeling well, n (%) |
|
| Very good |
1627 (48) |
| Good |
1221 (36) |
| Average |
431 (13) |
| Bad |
87 (3) |
| Very bad |
49 (1) |
| Self-assessed asthma level over previous 7 days versus general level‡, n (%) |
|
| Relatively good |
2498 (73) |
| Relatively bad |
871 (26) |
|
Definition of abbreviations: ICS=inhaled corticosteroids; LABA=long-acting β2-agonist; SD=standard deviation. *Data not available for 30 patients. †Data not available for 4 patients. Data not available for 46 patients. | |
Partridge et al. BMC Pulmonary Medicine 2006 6:13 doi:10.1186/1471-2466-6-13 |
|